Antiseptic efficacy and tolerance of tissue-tolerable plasma compared with two wound antiseptics on artificially bacterially contaminated eyes from commercially slaughtered pigs

Skin Pharmacology and Physiology

Volumn 23, Issue 6, 2010, Pages 328-332

  Hammann, A ^a   Huebner, N O ^a   Bender, C ^a   Ekkernkamp, A ^c   Hartmann, B ^c   Hinz, P ^a   Kindel, E ^b   Koban, I ^a   Koch, S ^e   Kohlmann, T ^a   Lademann, J ^d   Matthes, R ^a   Muller G ^a   Titze, R ^b   Weltmann, K D ^c   Kramer, A ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b LEIBNIZ INSTITUTE FOR PLASMA SCIENCE AND TECHNOLOGY   (Germany)

^c Burn Center   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Helios Klinik   (Germany)

Author keywords

Antiseptic efficacy; Eye antisepsis of slaughtered pigs; Polyhexanide; Povidone iodine; Tissue tolerance; Tissue tolerable plasma

Indexed keywords

ANTIINFECTIVE AGENT; LAVASEPT; POLYHEXANIDE; POVIDONE IODINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTISEPSIS; ARTICLE; BACTERIUM CONTAMINATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; EYE; HISTOPATHOLOGY; NONHUMAN; PLASMA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SLAUGHTERHOUSE; STAPHYLOCOCCUS AUREUS; SWINE; TISSUE TOLERABLE PLASMA; WOUND CARE;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTISEPSIS; BACTERIA; BIGUANIDES; COLONY COUNT, MICROBIAL; CORNEA; PLASMA GASES; POVIDONE-IODINE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SWINE; WOUNDS AND INJURIES;

EID: 77953937468     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314724     Document Type: Article

References (30)

1. Mulder GD, Cavorsi JP, Lee DK: Polyhexa-methylene biguanide (PHMB): an addendum to current topical antimicrobials. Wounds 2007; 19: 173-182.
2. Daeschlein G, Assadian O, Bruck JC, Meinl C, Kramer A, Koch S: Feasibility and clinical applicability of polihexanide for treatment of second-degree burn wounds. Skin Pharmacol Physiol 2007; 20:292-296.
3. Hansmann F, Kramer A, Ohgke H, Strobel H, Muller M, Geerling G: Lavasept as an alternative to PVP-iodine as a preoperative antiseptic in ophthalmic surgery. Randomized, controlled, prospective double-blind trial. Ophthalmologe 2005; 102:1043-1050.
4. Speaker MG, Menikoff JA: Prophylaxis of endophthalmitis with topical povidone-io-dine. Ophthalmology 1991; 98:1769-1775.
5. Reimer K, Vogt PM, Broegmann B, Hanser J, Rossbach O, Kramer A, Rudolph P, Bosse B, Schreier H, Fleischer W: An innovative topical formulation for wound healing and infection treatment: in vitro and in vivo investigations of a povidone iodine liposome hydrogel. Dermatology 2000; 198: 235-241.
6. Dormans JA, von Logten MJ: The effects of ophthalmic preservatives on corneal epithelium of the rabbit: a scanning electron microscopical study. Toxicol Appl Pharmacol 1982; 62: 251-261.
7. Kramer A: Requirements concerning antiseptics for periorbital, orbital and intraorbit-al application. Local tolerance. Dev Ophthalmol 2002; 33:32-56.
8. Bender C, Matthes R, Kindel E, Kramer A, Lademann J, Weltmann KD, Eisenbeiss W, Huebner NO: The irritancy potency of non-thermal atmospheric pressure plasma in the HET-CAM. Plasma Proc Polymers DOI: 10.1002/ppap. 200900119.
9. Kramer A, Rudolph P: Efficacy and tolerance of selected a ntiseptic substances in respect of suitability for use on the eye. Dev Ophthal-mol 2002; 33:117-144.
10. Foest R, Kindel E, Ohl A, Stieber M, Welt-mann KD: Non-thermal atmospheric pressure discharges for surface modification. Plasma Physics Contr Fusion 2005; 12B:B525.
11. Weltmann KD, Brandenburg R, von Woedtke T, Ehlbeck J, Foest R, Stieber M, Kindel E: Antimicrobial treatment of heat sensitive products by miniaturized atmospheric pressure plasma jets (APPJs). J Physics D: Appl Physics 2008; 19: 194008.
12. Geerling G, Baatz J, Harder D, Müller G, Reimer K, Rudolph P, Kramer A: Local tolerance. Dev Ophthalmol 2002; 33:32-56.
13. Hartung T: Toxicology for the twenty-first century. Nature 2009; 460:208-212.
14. Hoffmann G: Principles and working mechanisms of water-filtered infrared-A (wIRA) in relation to wound healing. GMS Kranken-haushyg Interdiszip 2007; 2:Doc54.
15. Eisenbeiss W: Stellenwert und Vorgehens-weise des chirurgischen Debridements. GMS Krankenhaushyg Interdiszip 2007; 2:Doc64.
16. Ovington L: Bacterial toxins and wound healing. Ostomy Wound Manage 2003; 49: 8-12.
17. Mueller G, Kramer A: Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 2008; 6:1281-1287.
18. Hartel M, Hoffmann G, Wente MN, Marti-gnoni ME, Buechler MW, Friess H: Randomized clinical trial of the influence of local water-filtered infrared A irradiation on wound healing after abdominal surgery. Br J Surg 2006; 93: 952-960.
19. Mercer JB, Nielsen SP, Hoffmann G: Improvement of wound healing by water-filtered infrared-A (wIRA) in patients with chronic venous stasis ulcers of the lower legs including evaluation using infrared ther-mography. GMS Ger Med Sci 2008; 6:Doc11.
20. Daeschlein G, Assadian O, Kloth LC, Meinl C, Ney F, Kra mer A: A nt ibac teria l act ivity of positive and negative polarity low-voltage pulsed current (LVPC) on six typical Gram-positive and Gram-negative bacterial pathogens of chronic wounds. Wound Repair Re-gen 2007; 15:399-403.
21. Zhao M: Electrical fields in wound healing-an overriding signal that directs cell migration. Semin Cell Dev Biol 2009; 20:674-682.
22. Tai G, Reid B, Cao L, Zhao M: Electrotaxis and wound healing: experimental methods to study electric fields as a directional signal for cell migration. Methods Mol Biol 2009; 571:77-97.
23. Ehlbeck J, Brandenburg R, von Woedtke T, Krohmann U, Stieber M, Weltmann KD: Plasmose-antimicrobial effects of modular atmospheric plasma sources. GMS Kranken-haushyg Interdiszipl 2008; 3:Doc14.
24. Koban I, Huebner NO, Matthes R, Welk A, Kindel E, Weltmann KD, Kramer A, Kocher T: Antiseptic efficacy of selected agents and tissue tolerable plasma (TTP) on C. albicans biofilms-has the biofilm maturity inf luence on it? GMS Krankenhaushyg Interdiszip 2009; 4:Doc09.
25. Matthes R, Bender C, Huebner NO, Mueller G, Kohl K, Mentz J, Koban I, Kindel E, Ko-cher T, Weltmann KD, Lademann J, Kramer A: Influencing of the penetration of Pseudo-monas aeruginosa into a 3-D epidermis model and the inactivation with tissue tolerable plasma. GMS Krankenhaushyg Interdiszip 2009; 4:Doc08.
26. Lademann J, Richter H, Alborova A, Humme B, Patzelt A, Kramer A, Weltmann KD, Hartmann B, Ottomann C, Fluhr JW, Hinz P, Huebner NO, Lademann O: Risk assessment of the application of a plasma-jet in dermatology. J Biomed Opt 2009; 14:054025.
27. Kramer A, Huebner NO, Assadian O, Below H, Bender C, Benkhai H, Broeker B, Ek kernkamp A, Eisenbeiss W, Hammann A, Hartmann B, Heidecke CD, Hinz P, Koban I, Koch S, Kocher T, Lademann J, Ladema nn O, Lerch MM, Maier S, Matthes R, Mueller G, Partecke I, Raendler C, Weltmann KD, Zyg-munt M: Chances and perspectives of the plasma medicine by use of tissue tolerable plasma (TTP). GMS Krankenhaushyg Inter-diszip 2009; 4:Doc10.
28. Stoffels E: Tissue processing with atmospheric plasmas. Contrib Plasma Phys 2007; 47:40-48.
29. Rajnicek AM, Foubister LE, McCaig CD: Growth cone steering by a physiological electric field requires dynamic microtubules, microfilaments and Rac-mediated filopodial asymmetry. J Cell Sci 2006; 119:1736-1745.
30. Weltmann KD, Kindel E, Brandenburg R, Meyer C, Bussiahn R, Wilke C, von Woedtke T: Atmospheric pressure plasma jet for medical therapy: plasma. Parameters and risk estimation. Contrib Plasma Phys 2009; 49:674-683.